Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Carbadox
Nuclear Receptor Subfamily 4, Group A, Member 3
The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double-blind, placebo-controlled study.
The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.
The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary. Pediatrics. 2017 06; 139(Suppl 3):S147-S152.
View in:
PubMed
subject areas
Child
DNA Mutational Analysis
Female
Forecasting
Fragile X Mental Retardation Protein
Fragile X Syndrome
Health Services Needs and Demand
Humans
Interdisciplinary Communication
Intersectoral Collaboration
Male
Organizational Objectives
Pregnancy
Research
Stakeholder Participation
Trinucleotide Repeats
United States
authors with profiles
Elizabeth Berry-Kravis